Lenalidomide Treatment Report : PatientsLikeMe

Filter by:

All
Start typing to see suggestions

patients

Home > Community Treatment Reports and Side Effects > Lenalidomide Treatment Report

You appear to have JavaScript disabled in your browser. PatientsLikeMe relies on JavaScript and Cookies to deliver the best possible experience to you. How do I enable JavaScript?

What is Lenalidomide?

Lenalidomide is an anticancer agent available under the brand name Revlimid®. It is used in the treatment of myelodysplastic syndrome (MDS) in patients with deletion 5q cytogenetic abnormality and for treatment of multiple myeloma. Off label used for metastatic malignant melanoma and myelofibrosis.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose	# of patients	# of patients with evaluations Efficacy	Major	Moderate	Slight	None	Can’t tell
Multiple Myeloma	1	0

See 1 patient currently taking Lenalidomide

Mouse over the table for more information

Reported Dosages

	25 mg daily
	1

Reported Duration See details about how long patients take this treatment ▼ Reported Duration Hide details ▲

Currently Taking Lenalidomide

A bar graph

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	1	0	0	0

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 09, 2012.